RecruitingPhase 2NCT06791070
A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum
Studying Extramammary Paget disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fujian Medical University Union Hospital
- Principal Investigator
- Shaoxing Zhu, DoctorFujian Medical University Union Hospital
- Intervention
- Disitamab Vedotin combined with Toripalimab(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-80 years · MALE
- Timeline
- 2025 – 2028
Study locations (1)
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Collaborators
Zhejiang Tumor Hospital · Fujian Provincial Hospital · Zhangzhou Affiliated Hospital of Fujian Medical University · Quanzhou First Hospital · First Affiliated Hospital of Wenzhou Medical University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06791070 on ClinicalTrials.govOther trials for Extramammary Paget disease
Additional recruiting or active studies for the same condition.